Contract 36C26025F0145
Takeda Pharmaceuticals America Inc · Department Of Veterans Affairs · October 16, 2025
Takeda Pharmaceuticals America Inc was awarded a federal contract by Department Of Veterans Affairs on October 16, 2025 for $19,000 (current value) of work in pharmaceutical preparation manufacturing. Performance is in Dublin, OH. This is a task or delivery order issued under parent IDIQ V797D50492. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 7, 2026. If all options are exercised, the contract could reach $19,000.
Contract details
- PIID
- 36C26025F0145
- Parent IDIQ
- V797D50492
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Dublin, OH
- First action
- October 16, 2025
- Latest action
- January 7, 2026
Description
BULK MARIBAVIR 200MG TABS - PRICE CHANGE FOR 2 BTS.
Modification timeline
-
January 7, 2026Mod P00002 · Other Administrative Action$18.7K
-
October 16, 2025Mod P00001 · Funding Only Action$112.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26025F0145?
Contract 36C26025F0145 is a federal contract awarded to Takeda Pharmaceuticals America Inc by Department Of Veterans Affairs on October 16, 2025 for $19,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36C26025F0145?
Takeda Pharmaceuticals America Inc won contract 36C26025F0145 from Department Of Veterans Affairs.
How much is contract 36C26025F0145 worth?
Contract 36C26025F0145 has obligated $0 to date but carries a potential ceiling of $19,000 if fully funded and all options are exercised.